Similarly, Fhl1, linked to cardiomyopathy and muscle metabolism [49,50], gained significance (Padj = 0.477 to 5.27e-04), potentially connecting α1A-AR’s anti-glycolytic function [51] to Fhl1 activity. The gene discussed is FHL1; the disease is cardiomyopathy.